On August 11, 2026, Brian Yoor notified iRhythm Holdings, Inc. of his resignation from the Board of Directors and as chair of the Audit Committee, effective August 12, 2026. The departure was for personal reasons and not due to disagreements regarding operations or policies. Karen McGinnis has been appointed as the new chair of the Audit Committee, also effective August 12, 2026. iRhythm Holdings, Inc. operates in the medical technology industry, specializing in ambulatory cardiac monitoring solutions.

On August 5, 2026, iRhythm Holdings, Inc. entered into an Agreement and Plan of Merger to acquire Vital Connect, Inc. The transaction involves aggregate consideration consisting of $237.5 million in cash and shares of iRhythm common stock valued at $50 million. Outstanding Target options will be cancelled without consideration, while vested and in-the-money warrants are eligible for equity consideration. An interim funding agreement provides up to $30.0 million in pre-closing operational support, with an initial $10.0 million grant. The acquisition is expected to close by the end of 2026, subject to stockholder approval and Hart-Scott-Rodino antitrust clearance. iRhythm operates in the digital health industry, developing wearable cardiac monitoring devices.

iRhythm Holdings, Inc. reported a material cybersecurity incident involving unauthorized activity in third-party-hosted business applications on June 8, 2026. A threat actor claimed to have exfiltrated sensitive information, including proprietary data and patient protected health information, and demanded payment to prevent disclosure. The company determined the incident is material, though it has not identified any impact to its clinical, medical device systems, or financial reporting systems. iRhythm Holdings, Inc. is a healthcare technology company providing cardiac monitoring services.